Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: ICON 4Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: ICON 4Q

Operating income was $92 million for the year, representing 10.2% of revenue.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q

4Q Revenues: $232.1 million (+2%)

4Q Earnings: $22.1 million (-8%)

FY Revenues: $900.0 million (+1%)

FY Earnings: $87.1 million (-5%)

Comments: Operating income was $92 million for the year, representing 10.2% of revenue. This comprised clinical services operating income of $104.8 million or 12.5%, and central lab operating losses of $12.8 million. In the quarter, operating income was $22 million, representing 9.5% of revenue. Clinical services operating income accounted for $26 million or 12.1%, and a central lab operating loss of $4 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters